A Review of cardiac transplantation

Anesthesiology Clinics

Volumn 31, Issue 2, 2013, Pages 383-403

  Fischer, Sofia ^a   Glas, Kathryn E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac transplantation; Circulatory support; Donor criteria; Recipient selection

Indexed keywords

ADRENALIN; ARGATROBAN; DANAPAROID; DOBUTAMINE; EPHEDRINE; ETOMIDATE; FENTANYL; FRESH FROZEN PLASMA; GLYCERYL TRINITRATE; HEPARIN; HIRULOG; ISOPRENALINE; LEPIRUDIN; LEVOSIMENDAN; MIDAZOLAM; MILRINONE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; PHENYLEPHRINE; PROSTACYCLIN; PROSTAGLANDIN E1; VASOPRESSIN;

ACUTE GRAFT REJECTION; AGE; ASSISTED CIRCULATION; BLOOD GROUP ABO SYSTEM; BODY HEIGHT; BODY WEIGHT; BRAIN DEATH; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CLINICAL EVALUATION; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; DEVICE INFECTION; DIASTOLIC HEART FAILURE; DISABILITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXTRACORPOREAL OXYGENATION; GENDER; GENERAL ANESTHESIA; GRAFT DYSFUNCTION; GRAFT FAILURE; GRAFT RECIPIENT; HEALTH INSURANCE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PACING; HEART PRESERVATION; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HISTORY OF MEDICINE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTERNATIONAL NORMALIZED RATIO; LEFT VENTRICULAR ASSIST DEVICE; LONG TERM SURVIVAL; LUNG VASCULAR RESISTANCE; MULTIPLE ORGAN FAILURE; ORGAN DONOR; PATIENT SELECTION; PLASMAPHERESIS; PREOPERATIVE EVALUATION; PROGNOSIS; PULMONARY HYPERTENSION; QRS COMPLEX; REPERFUSION INJURY; RETRANSPLANTATION; RETURN TO WORK; REVIEW; SINUS RHYTHM; STERNOTOMY; SURGICAL MORTALITY; SURVIVAL RATE; SYSTOLIC DYSFUNCTION; THORAX RADIOGRAPHY; WEANING;

CARDIOPULMONARY BYPASS; EXTRACORPOREAL MEMBRANE OXYGENATION; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; PREOPERATIVE CARE; REOPERATION; TISSUE AND ORGAN PROCUREMENT;

EID: 84878625587     PISSN: 19322275     EISSN: 22103538     Source Type: Journal    
DOI: 10.1016/j.anclin.2013.01.003     Document Type: Review

References (82)

1. Boilson B.A., Raichlin E., Park S.J., et al. Device therapy and cardiac transplantation for end-stage heart failure. Curr Probl Cardiol 2010, 35:8-64.
2. Miller L.W. Left ventricular assist devices are underutilized. Circulation 2011, 123:1552-1558.
3. Stehlik J., Edwards L.B., Kucheryavaya A.Y., et al. The registry of the International Society for Heart and lung transplantation: twenty-eighth adult heart transplant report-2011. J Heart Lung Transplant 2011, 30:1078-1094.
4. Willman V.L., Cooper T., Cian L.G., et al. Auto-transplantation of the canine heart. Surg Gynecol Obstet 1962, 115:299-302.
5. Lower R.R., Dong E., Shumway N.E. Suppression of rejection crisis in the cardiac homograph. Ann Thorac Surg 1965, 1:645-649.
6. Barnard C.N. The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J 1967, 41:1271-1274.
7. Kantrowitz A., Haller J.D., Joos H., et al. Transplantation of the heart in an infant and an adult. Am J Cardiol 1968, 22(6):782-790.
8. Cauls P.K., Stinson E.B., Billingham M.E., et al. Diagnosis of human cardiac allograft rejection by serial cardiac biopsy. J Thorac Cardiovasc Surg 1973, 66:461-466.
9. Milla F., Pinney S.P., Anyanwu A.C. Indications for heart transplantation in the current of left ventricular assist devices. Mt Sinai J Med 2012, 79:305-316.
10. 2010 Annual Report of the U.S. Organ Procurement and Transplantation Network and the scientific registry of transplant recipients: 1998-200. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA.
11. Stewart G.C., Givertz M.M. Mechanical circulatory support for advanced heart failure: patients and technology in evolution. Circulation 2012, 125:1304-1315.
12. Mehra M.R., Kobashigawa J., Starling R., et al. Listing criteria for heart transplantation: International Sciety fo Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates - 2006. J Heart Lung Transplant 2006, 25:1024-1042.
13. Nicolini F., Gherli T. Alternatives to transplantation in the surgical therapy for heart failure. Eur J Cardiothorac Surg 2009, 35:214-228.
14. Hunt S.A., Abraham W.T., Chin M.H., et al. 2009 Focus update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. Circulation 2009, 53:e1-e90.
15. Augoustides J.G., Rhia H. Recent progress in heart failure treatment and heart transplantation. J Cardiothorac Vasc Anesth 2009, 23:738-748.
16. Shuhaiber J.H., Kim J.B., Hur K., et al. Comparison of survival in primary and repeat heart transplation from 1987 through 2004 in the United States. Ann Thorac Surg 2007, 83:2135-2141.
17. Kirk R., Edwards L.B., Kucheryavaya A.Y., et al. The registry of the International Society for Heart and lung Transplantation: fourteenth pediatric heart transplantation report-2011. J Heart Lung Transplant 2011, 30:1095-1103.
18. Mancini D., Lietz K. Selection of cardiac transplant candidates in 2010. Circulation 2010, 122:173-183.
19. Hunt S.A., Haddad F. The changing face of heart transplantation. J Am Coll Cardiol 2008, 52:587-598.
20. Bittner H.B. Extra-corporeal membrane oxygenation support in cardiac transplantation. Appl Cardiopulm Pathophysiol 2011, 15:272-277.
21. Ibrahim M., Hendry P., Masters R., et al. Management of acute severe perioperative failure of cardiac allografts: a single-centre experience with a review of the literature. Can J Cardiol 2007, 23:363-367.
22. Johnson M.R., Aaronson K.D., Canter C.E., et al. Heart retransplantation. Am J Transplant 2007, 7:2075-2081.
23. Vega J.D., Moore J., Murray S., et al. Heart transplantation in the United States, 1998-2007. Am J Transplant 2009, 9:932-941.
24. Rose E.A., Gellijns A.C., Moskowitz A.J., et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001, 345:1435-1443.
25. Kirlin J.K., Naftel D.C., Kormos R.L., et al. Third INTERMACS annual report: the evolution of destination therapy in the United States. J Heart Lung Transplant 2011, 30:115-123.
26. John R., Pagani F.D., Naka Y., et al. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. J Thorac Cardiovasc Surg 2010, 140:174-181.
27. Kirlin J.K., Naftel D.C., Kormos R.L., et al. The fourth INTERMACS annual report: 4,000 implants and counting. J Heart Lung Transplant 2012, 31:117-126.
28. Levy W.C., Mozaffarian D., Linker D.T., et al. The Seattle heart failure model: prediction of survival in heart failure. Circulation 2006, 113:1424.
29. Vega J.D. The change in heart allocation policy in the United States: is it working as designed?. J Heart Lung Transplant 2010, 29:255-256.
30. Felker G.M., Milano C.A., Yager E.E., et al. Outcomes with an alternate list strategy for heart transplantation. J Heart Lung Transplant 2005, 24:1781-1786.
31. Chen J.M., Russo M.J., Hammond K.M., et al. Alternate waiting list strategies for heart transplantation maximize donor organ utilization. Ann Thorac Surg 2005, 80:224-228.
32. Laks H., Marelli D., Fonarow G.C., et al. Use of two recipient lists for adults requiring heart transplantation. J Thorac Cardiovasc Surg 2003, 125:49-59.
33. Ramakrishna H., Jaroszewski D.E., Arabia F.A. Adult cardiac transplantation: a review of perioperative management part-I. Ann Card Anaesth 2009, 12:71-78.
34. Grauhan O. Screening and assessment of the donor heart. Appl Cardiopulm Pathophysiol 2011, 15:191-197.
35. Costanzo M.R., Taylor D., Hunt S., et al. The International Society of Heart and Lung Transplantation guideline for the care of heart transplant recipients. J Heart Lung Transplant 2010, 29:914-956.
36. Kuppahally S.S., Valantine H.A., Weisshaar D., et al. Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness. Am J Transplant 2007, 7:2388-2395.
37. Weiss E.S., Allen J.G., Patel N.D., et al. The impact of donor-recipient sex matching on survival after orthotopic heart transplantation - analysis of 18,000 transplants in the modern era. Circ Heart Fail 2009, 2:401-408.
38. Yamani M.H., Erinc K., Starling R.C., et al. Donor intracranial bleeding is associated with advanced transplant coronary vasculopathy: evidence from intravascular ultrasound. Transplant Proc 2004, 36:2564-2566.
39. D'ancona G., Santise G., Falleta C., et al. Primary graft failure after heart transplantation: the importance of donor pharmacological management. Transplant Proc 2010, 42:710-712.
40. Conway J., Dipchand A.I. Heart transplantation in children. Pediatr Clin North Am 2010, 57:353-373.
41. Wagner F.M. Donor heart preservation and perfusion. Appl Cardiopulm Pathophysiol 2011, 15:198-206.
42. Russo M.J., Chen J.M., Sorabella R.A., et al. The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg 2007, 133:554-559.
43. Yeter R., Hubler M., Pasic M., et al. Organ preservation with the organ care system. Appl Cardiopulm Pathophysiol 2011, 15:207-212.
44. Ghodsizad A., Bordel V., Ungerer M., et al. Ex vivo coronary angiography of a donor heart in the Organ Care System. Heart Surg Forum 2012, 15(3):E161-E163.
45. Gaitan B.D., Thunberg C.A., Stansbury L.G., et al. Development, current status, and anesthetic management of the implanted heart. J Cardiothorac Vasc Anesth 2011, 25:1179-1192.
46. Denault A., Deschamps A. Abnormal aortic-to-radial arterial pressure gradients resulting in misdiagnosis of hemodynamic instability. Can J Anaesth 2009, 56:534-536.
47. Koster A., Diehl C., Dongas A., et al. Anesthesia for cardiac transplantation: a practical overview of current management strategies. Appl Cardiopulm Pathophysiol 2011, 15:213-219.
48. Troianos C.A., Hartman G.S., Glas K.E., et al. Guidelines for performing ultrasound guided vascular cannulation: recommendation of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr 2012, 114:46-69.
49. Waterman P.M., Bjerke R. Rapid-sequence induction technique in patients with severe ventricular dysfunction. J Cardiothorac Anesth 1988, 2:602-606.
50. Hensley F., Martin D.E., Larach D.R., et al. Anesthetic management for cardiac transplantation in North America - 1986 survey. J Cardiothorac Anesth 1987, 1:429.
51. Demad K., Wyner J., Mihm F.G., et al. Anaesthesia for heart transplantation. A retrospective study and review. Br J Anaesth 1986, 58:1357.
52. Shanewise J. Cardiac transplantation. Anesthesiol Clin North America 2004, 22:753-765.
53. Levy J.H., Winkler A.M. Heparin-induced thrombocytopenia and cardiac surgery. Curr Opin Anaesthesiol 2010, 23:74-79.
54. Wadia Y., Cooper J.R., Bracey A.W., et al. Intraoperative anticoagulation management during cardiac transplantation. Tex Heart Inst J 2008, 35:62-65.
55. Christiansen S., Hammel D., Schmidt C., et al. Heparin in patients with heparin-induced thrombocytopenia type II requiring LVAD implantation and cardiac transplantation. J Heart Lung Transplant 2000, 19:510-512.
56. Warkentin T.E., Greinacher A., Koster A., et al. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008, 133:340S-380S.
57. Levy J.H., Tanaka K.A., Hursting M.J., et al. Reducing thrombotic complications in perioperative setting: an update on heparin-induced thrombocytopenia. Anesth Analg 2007, 105:570-582.
58. Welsby I.J., Um J., Milano C.A., et al. Plasmapheresis and heparin reexposure as a management strategy for cardiac surgical patients with heparin-induced thrombocytopenia. Anesth Analg 2010, 110:30-35.
59. Robinson J.A., Lewis B.E. Plasmapharesis in the management of heparin induced thrombocytopenia. Semin Hematol 1999, 36:29-32.
60. Abdel-Razeq H.N., Bajouda A.A., Khalil M.M., et al. Treating heparin-induced thrombocytopenia the unconventional way!. Saudi Med J 2004, 25:1258-1260.
61. Shumway N.E., Lower R., Stofer R.C. Transplantation of the heart. Adv Surg 1966, 2:265-284.
62. Sievers H.H., Weyand M., Kraatz E.G., et al. An alternative technique for orthotopic cardiac transplantation, with preservation of the normal anatomy of the right atrium. J Thorac Cardiovasc Surg 1991, 39:70-72.
63. Schnoor M., Schafer T., Luhmann D., et al. Bicaval versus standard technique in orthotopic heart transplantation: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 2007, 134:1322-1331.
64. Davies R.R., Russo M.J., Morgan J.A., et al. Standard versus bicaval techniques for orthotopic transplantation: an analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg 2010, 140:700-708.
65. Yacoub M., Mankad P., Ledingham S., et al. Donor procurement and surgical technique for cardiac transplantation. Semin Thorac Cardiovasc Surg 1990, 2:153-161.
66. Carrel A., Guthrie C.C. the transplantation of veins and organs. Am Med 1905, 10:1101-1102.
67. Jacquet L., Ziady G., Stein K., et al. Cardiac rhythm disturbances early after orthotopic heart transplantation: prevalence and clinical importance of the observed abnormalities. J Am Coll Cardiol 1990, 16:832-837.
68. Wagner F. Monitoring and management of right ventricular function following cardiac transplantation. Appl Cardiopulm Pathophysiol 2011, 15:220-229.
69. Russo M.J., Iribarne A., Hong K.M., et al. Factors associated with primary graft failure after heart transplantation. Transplantation 2010, 90:444-450.
70. Taghavi S., Zuckermann A., Ankersmit J., et al. Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation. Ann Thorac Surg 2004, 78:1644-1649.
71. Anavekar N.C., Gerson D., Skali H., et al. Two-dimensional assessment of right ventricular function: an echocardiographic MRI correlative study. Echocardiography 2007, 24:452-456.
72. Augoustides J.G., Ochroch E.A. Inhaled selective pulmonary vasodilators. Int Anesthesiol Clin 2005, 43(2):101-114.
73. Mubarak K.K. A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension. Respir Med 2010, 104:9-21.
74. Khan T.A., Schnickel G., Ross D., et al. A prospective randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients. J Thorac Cardiovasc Surg 2009, 138:1417-1424.
75. Creagh-Brown B.C., Griffiths M.J., Evans T.W. Bench-to-bedside review:inhaled nitric oxide therapy in adults. Crit Care 2009, 13:212.
76. Vlahakes G.J. Right ventricular failure after cardiac surgery. Cardiol Clin 2012, 30:283-289.
77. Boffini M., Sansone F., Ceresa F., et al. Role of oral sildenafil in the treatment of right ventricular dysfunction after heart transplantation. Transplant Proc 2009, 41:1353-1356.
78. Weis F., Beiras-Fernandez A., Kaczmarek I., et al. Levosimendan: a new therapeutic option in the treatment of primary graft dysfunction after heart transplantation. J Heart Lung Transplant 2009, 28:501-504.
79. Petersen J.W., Felker G.M. Inotropes in the management of acute heart failure. Crit Care Med 2008, 36:S106-S111.
80. Ranasinghe A.M., Bonser R.S. Thyroid hormone in cardiac surgery. Vascul Pharmacol 2010, 52:131-137.
81. Takhavi S., Ankersmit A., Zuckerman G.A., et al. A retrospective analysis of extracorporeal membrane oxygenation versus right ventricular assist device in acute graft failure after heart transplantation. Transplant Proc 2003, 35:2805-2807.
82. Marasco S.F., Esmore D.S., Negri J., et al. Early institution of mechanical support improves outcomes in primary cardiac allograft failure. J Heart Lung Transplant 2005, 24:2037-2042.